Why Now Is Not The Time To Buy Valeant Pharmaceuticals

Just a few short years ago, Valeant Pharmaceuticals (NYSE: VRX) was a red-hot stock. The company's CEO at the time, Michael Pearson, was hailed as a genius and was the toast of Wall Street. Several big-name hedge funds even piled into the stock with the hope of striking it rich. Unfortunately, the company's business practices proved to be unsustainable, which set off a nasty chain reaction.

Topics:  valeant pharmaceuticals nyse   vrx    ceo   michael pearson   wall   street   images   time   stock   company   
BING NEWS:
  • Equinix: A Buy After Questioning Hindenburg's Allegations
    Equinix's share price dropped over 20% due to allegations made by a short-seller, including manipulative practices by top management. Find out why EQIX stock is a Buy.
    05/2/2024 - 1:18 am | View Link
  • More

 

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Business News